Psychopharmacology Update 2021

Download All
This comprehensive program includes a current review of diagnostic and therapeutic issues and options and explores innovative treatment approaches in patients with various psychiatric conditions such as mood and anxiety disorders, schizophrenia, and ADHD. Premenstrual, perinatal, and perimenopausal depression are also covered. Learners can access webcasts and downloadable slides for future reference and use.
Jonathan M. Meyer, MD

Pharmacotherapy of Antipsychotic-Induced Movement Disorders

In this interactive recording of a live CCO webinar, Jonathan M. Meyer, MD, discusses pharmacotherapy of antipsychotic-induced movement disorders and reviews the 2021 American Psychiatric Association recommendations on managing antipsychotic-induced parkinsonism, acute dystonia, akathisia, and tardive dyskinesia (TD); the rationale for avoiding routine or prolonged anticholinergic use to manage antipsychotic-related parkinsonism or dystonia; why anticholinergics worsen TD; and the latest recommendations on effective TD management.

Jonathan M. Meyer, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Social Workers: 1.0 ACE CE Credit Psychologists: 1.0 APA CE Credit Released: February 16, 2022 Expired: February 15, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings